Xiaolin Yang

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 27, 2026

Consistent Detection of Aquaporin-4 Antibodies: A Comparative Analysis Between Fixed and Live Cell-Based Assays.

Consistent Detection of Aquaporin-4 Antibodies: A Comparative Analysis Between Fixed and Live Cell-Based Assays.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: June 16, 2025

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab.

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab.

Journal: Frontiers in neurology

Published: January 11, 2025

Brain network alteration was associated with 'no evidence of disease activity' status in patients with relapsing-remitting multiple sclerosis.

Brain network alteration was associated with 'no evidence of disease activity' status in patients with relapsing-remitting multiple sclerosis.

Journal: Journal of neuroimmunology

Published: November 15, 2024

Advances in the treatment of neuromyelitis optic spectrum disorder.

Advances in the treatment of neuromyelitis optic spectrum disorder.

Journal: Therapeutic advances in neurological disorders

Published: September 12, 2024

Efgartigimod as rescue treatment in acute phase of neuromyelitis optica spectrum disorder: A Case Report.

Efgartigimod as rescue treatment in acute phase of neuromyelitis optica spectrum disorder: A Case Report.

Journal: Heliyon

Published: February 28, 2024

Landscapes of gut microbiome and blood metabolomic signatures in relapsing remitting multiple sclerosis.

Landscapes of gut microbiome and blood metabolomic signatures in relapsing remitting multiple sclerosis.

Journal: Science China. Life sciences

Published: February 07, 2024

Identification of Y‒linked biomarkers and exploration of immune infiltration of normal-appearing gray matter in multiple sclerosis by bioinformatic analysis.

Identification of Y‒linked biomarkers and exploration of immune infiltration of normal-appearing gray matter in multiple sclerosis by bioinformatic analysis.

Journal: Heliyon

Published: May 15, 2023

Rasd1 is involved in white matter injury through neuron-oligodendrocyte communication after subarachnoid hemorrhage.

Rasd1 is involved in white matter injury through neuron-oligodendrocyte communication after subarachnoid hemorrhage.

Journal: CNS neuroscience & therapeutics

Published: January 31, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026